Redirection of SARS-CoV-2 to phagocytes by intranasal sACE2-Fc as a universal decoy confers complete prophylactic protection
Open Access
- 18 May 2026
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Abstract
The rapid evolution of SARS-CoV-2 and other respiratory RNA viruses limits the success of current vaccines and antibody-based therapies. Engineered decoy receptors based on soluble angiotensin-converting enzyme 2 (sACE2) offer promising alternatives but show limited clinical success. This study conducted functional and mechanistic analyses using an optimized sACE2 mutant fused to human IgG1 Fc (B5-D3) as a representative, revealing redirection of virus–decoy complexes from epithelial infection to lysosomal degradation in phagocytes beyond viral neutralization. Intranasal prophylactic delivery of B5-D3 confers complete protection in SARS-CoV-2-infected K18-hACE2 mice, regardless of age. Abrogation of Fc effector functions compromises antiviral protection, indicating that Fc-mediated uptake of virus–decoy complexes is critical. Transcriptomic analysis suggests that B5-D3 induces early immune activation in the lungs of infected mice. Bio-distribution and flow cytometry reveal selective targeting of airway phagocytes. In vitro assays confirm lysosomal degradation of virus–decoy complexes by macrophages without productive infection. These findings reveal a distinct antiviral mechanism via phagocytic clearance, supporting refined regimens for decoy treatments against SARS-CoV-2 and potentially other respiratory viruses.Keywords
All Related Versions
Funding Information
- Research Grants Council, University Grants Committee (14115520)
- Research Grants Council, University Grants Committee (14106024)
- Research Grants Council, University Grants Committee (C7145-20GF)
- Innovation and Technology Commission (Health@InnoHK)
- Chinese University of Hong Kong (Postgraduate studentship)
This publication has 64 references indexed in Scilit:
- Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse modelGeroScience, 2024
- Kv1.3-dependent immune system activation is regulated by KCNE4Biophysical Journal, 2023
- COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysisJAMA Network Open, 2023
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsCell, 2022
- Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1Cell, 2022
- The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistanceCell Reports, 2021
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunityCell, 2021
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell, 2020
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2Cell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020